CureVac AG is a biopharmaceutical company researching and developing novel drugs based on the natural molecule Messenger RNA (mRNA). Our focus is on innovative cancer immunotherapies, prophylactic vaccines and molecular therapies. Currently, about 470 RNA people are striving to achieve our main goal: To bring the first mRNA-based drug worldwide to the market.
To strengthen our team in Tübingen near Stuttgart, we are currently looking to recruit an
Engineer (f/m/d) Bioassay Development & Analytics – Early Process Development
Job-ID: 3601 -2003